Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study.

Neurogastroenterol Motil · 2025 · PMC12435799 · PMID 40275512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Loperamide showed a trend toward longer drug survival than antispasmodics (log‐rank test 0.064) and bulking agents (log‐rank test 0.077).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.